China is one of the countries with the heaviest burden of liver disease, with a large number of people infected with hepatitis B and C. While China has achieved remarkable success in hepatitis prevention and control in recent years, many challenges remain in the fight against hepatitis. Public awareness, testing, and treatment rates for hepatitis need to be improved. Many patients seek treatment only after the disease has progressed to severe stages such as cirrhosis and liver cancer. The World Health Organization has set the goal of eliminating viral hepatitis by 2030, and the key to achieving this goal lies in early screening, diagnosis, and treatment.
In order to actively implement the deployment of the “Healthy China 2030” Outline, on July 28, 2025, during the 15th “World Hepatitis Day”, Eieling Technology, in conjunction with the Fangshan Community Health Service Center of Chunhua Street, Jiangning District, entered the Nanjing Life Science and Technology Town Park to carry out a two-day “World Hepatitis Day Charity Clinic” for the working population.
At the free clinic, the Eieling Technology team provided free liver screenings to participating employees, using the patented Liverscan® device to provide high-quality liver health assessments. The expert team also offered psychological screenings, blood pressure and blood sugar testing, and other services. They patiently answered questions and, based on individual medical histories, provided scientific health guidance on diet, lifestyle habits, and disease prevention.
Technology empowerment: accurate and efficient screening experience
During this free clinic, the Liverscan® portable liver elastography ultrasound diagnostic system brought by Eieling Technology attracted a lot of attention. With real-time image guidance and AI-assisted probe positioning, the device can automatically avoid interference from ribs to ensure accurate and reliable test results. Due to the hidden nature of liver disease in the early stages, the early screening rate is generally low. When many patients are diagnosed, their condition has already progressed to a more serious stage, and they have missed the best time for treatment.
This free clinic will bring innovative liver screening technology to employees. Quantitative liver fibrosis and liver fat values will help medical staff to promptly detect potential liver health problems in the general population, achieve early screening and early detection of liver disease, and thus carry out effective intervention. The design of Liverscan® fully considers the convenience of operation. Only a single probe is required to complete the entire detection process, which greatly shortens the detection time and attracts many employees to participate actively.
This free clinic is a concrete manifestation of Eieling Technology’s commitment to social responsibility and implementation of the “Healthy China 2030” Outline. By providing convenient and efficient health testing services, the company promotes the concept of strengthening hepatitis prevention and control to the public and increases employees’ awareness of their liver health.
On February 17th of this year, Eieling Technology’s FattaLab® Global Super Factory officially opened in Nanjing’s Jiangning District. This deployment will further support the establishment of China’s first “Community-Centered Chronic Liver Disease Management Demonstration Zone,” providing innovative solutions for liver disease prevention and control at the grassroots level. Looking ahead, Eieling Technology will actively promote the accessibility of liver disease testing equipment, allowing more people at the grassroots level to enjoy the health benefits of advanced medical technology. At the same time, Eieling Technology will continue to explore and innovate, making steady progress toward the development goals of liver health in my country and collaborating with all sectors of society to create a hepatitis-free future.